Previously submitted to: Journal of Medical Internet Research (no longer under consideration since Apr 13, 2023)
Date Submitted: Jul 21, 2022
Open Peer Review Period: Jul 21, 2022 - Sep 15, 2022
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Online forum for testosterone-related discussions may help guide educational initiatives from healthcare providers
ABSTRACT
Background:
Testosterone Replacement Therapy (TRT) has been growing in popularity with a 400% increase in use between 2003 and 2013 in men 15 – 45 years of age with subsequent doubling of TRT spending to $2 billion. Rapid increases in TRT use, coupled with barriers to care, likely contribute to use of online communities for discussion among those with common interests regardless of geographic location, social status, or time constraints. Such communities allow for anonymous inquiry through patient-controlled narrative that provides catharsis, validation, and peer support without being subjected to the high financial and time cost of hospitals or clinics.
Objective:
We aimed to characterize the most commonly asked questions in the r/Testosterone Reddit community to help guide healthcare provider educational initiatives.
Methods:
Publicly-available online Reddit community r/Testosterone posts were reviewed over two eight-day periods in February and October 2021. Content was classified into the following categories: side effects of testosterone, lifestyle and lifestyle changes, bloodwork, TRT protocols, supplemental therapy, over-the-counter (OTC) supplements, injection technique and site, and clinic/online services to obtain TRT.
Results:
The first data collection reviewed 277 questions with the most common questions categorized into requests to review bloodwork (50/227, 18.1%), inquiries about supplemental testosterone therapy options (41/227, 14.8%), and questions regarding TRT protocols (28/227, 10.1%). The second data collection reviewed 380 questions. Categorization of the most common questions were review of blood work (77/380, 20.3%) and TRT protocol (48/380, 12.6%). Questions regarding side effects were also commonly asked (and within the top three categories; 58/380 and 15.3%). New, unique questions posed included clinic or online service to obtain TRT and syringes (17/380, 4.5%) and inquiries about injection technique (14/380, 3.7%) and the injection site (9/380, 2.4%). There was a 1.7-fold participation increase from 227 to 380 questions between the two data collections, and over the course of the study, r/Testosterone membership increased from approximately 52,800 to over 73,000. TRT protocols and bloodwork review remained amongst the top three categories discussed between both data collections, whereas the first data set had more questions regarding supplemental therapies and the second data set had more emphasis on side effects of TRT therapy.
Conclusions:
Review of publicly-available online content specific to testosterone offers insight into relevant questions and concerns. Inquiries change over time, and therefore, we must evolve with our patient population. Use of online forums can guide the creation of relevant educational content.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.